AVDA ITR Advisor Newsletter
AVDA is pleased to announce that AVDA has partnered with ITR Economics to provide the monthly ITR Advisor, a 4-page snapshot of the current economy, using leading indicators to tell subscribers where the economy is headed and what actions to take now. Written in a conversational tone, not heavy economic-speak, the ITR Advisor is a simple, quick, timely, and affordable way to stay informed about the state of the economy, with useful guidance and clear action points. This is another member benefit that we are providing to our members. This email newsletter will be sent to all principals and alternates at AVDA member companies.
AVDA Welcomes New Board Members
The Annual Meeting and Elections of AVDA Active Members was held on Monday, April 28, 2014 in conjunction with the AVDA Annual Conference held at the Fairmont Scottsdale Princess in Scottsdale AZ. Paula Brown of Midwest Veterinary Supply was elected to serve a two year term as President-Elect. Meryl Weinstein of Henry Schein Animal Health was elected to serve a three year term as Active Member director. She replaces Ben Coe of Henry Schein Animal Health who completed his service on the board as Immediate Past Chairman and received a watch to commemorate his seven year tenure on the board.
DEA Approves Making Tramadol a Schedule IV Controlled Substance
The Drug Enforcement Administration (DEA) recently published its decision to schedule tramadol as a Schedule IV controlled substance. The rule will become effective August 18 of this year. The DEA's action was fairly swift, having published its proposal to schedule tramadol just eight months ago. Upon conducting its eight-step analysis, the DEA found that relative to Schedule III drugs, tramadol has a low potential for abuse and limited physical dependence, and coupled with tramadol's medical legitimacy, DEA determined Schedule IV to be the most fitting for tramadol. Click here for more.
AVDA recently submitted public comments in regards to the DEA's Federal Register notice of proposed rulemaking: Schedules of Controlled Substances: Placement of Tramadol Into Schedule IV.
AVDA supports DEA's proposed rule designating Tramadol as a scheduled IV controlled substance because this action will enable distributors to operate with efficiency and consistency across the states along with requiring an increased level of due diligence and monitoring. Tramad l is an important drug in veterinary medicine and is supplied to veterinarians and animal health clinics by our distributor members. Tramadol is administered to dogs, cats and many non-domestic animals as an analgesic and as a pain reliever after surgical procedures. Click here to read the full document.
Legal Update: FTC Enforcement Actions Continue
At the September, 2013 Board meeting I advised you of recent activity of the Federal Trade Commission pertaining to the exchange of sensitive business information by and between competitors (Federal Trade Commission v. Bosley, No. 121-0184). While the information exchange was clearly inadvisable, the Commission's position was not based upon any allegations of harm to competition. Rather, the Commission used its authority under Section 5 of the FTC Act to find the Respondent violated the Act solely by exchanging the information and presuming such an exchange could lead to an adverse impact on competition.
The FTC continues to scrutinize the activities of competitors and trade associations. The Commission recently published proposed consent orders in two cases involving trade associations which are discussed below. Click here to read the full update.